Astera Labs, Inc. (ALAB): what the price requires
At today's price, Astera Labs, Inc. (ALAB) is priced for today's economics sustained for ~40.0 years+. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high.
Generated: 2026-07-19 · Source: https://boothcheck.com/report/ALAB
Headline
| Field | Value |
|---|---|
| Ticker | ALAB |
| Company | Astera Labs, Inc. |
| Current price | $363.10/sh |
What The Price Requires (Inversion)
The assumption today's price embeds, recovered by inverting the valuation.
| Field | Value |
|---|---|
| Inversion basis | revenue-multiple |
| EV / sales paid | 69.8x |
| Steady-state operating margin assumed | 30.3% |
Beyond 25%/yr sustained for 40 years; not resolvable as a revenue bet. The inversion reports a bound, not a solved point.
Solve inputs: computed at a 14.9% cost of capital; growth searched up to the 25% self-funding ceiling.
Reconcile: at the x-ray's 9.3% required return this reads ~21.2 years; the models below use their own rates.
How unusual the bet is: extreme (limited comparison data)
| Reference | Value |
|---|---|
| sustained it ~5 years at this level | 34% |
| implied end-window share | 0% |
Valuation X-Ray
Every valuation family lands below the price. The price therefore requires assumptions beyond what those standard frames encode.
How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.
| Family | Median price/FV | Models | Reads |
|---|---|---|---|
| Asset | 16.59x | 2 | expensive |
| Earnings | 12.52x | 2 | expensive |
| Relative | 9.84x | 4 | expensive |
| Growth | 3.77x | 3 | expensive |
Families that call it expensive: Asset, Earnings, Relative, Growth
The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 9.2%); the inversion above states its own rate.
Per-Model Detail (n=11)
| Model | Family | FV | Price/FV | Applicable | Methodology |
|---|---|---|---|---|---|
| DCF Perpetual Growth | Growth | $85.99 | 4.22x | yes | FCF base $0.4B, growth 25% (input: historical growth), terminal g 4.0%, WACC 9.2%, 7yr projection |
| DCF Exit Multiple | Growth | $372.72 | 0.97x | yes | Exit EV/EBITDA: 278.6x / 281.6x / 284.6x (bear / base = today's held flat / bull), 7yr |
| Relative Valuation | Relative | $65.69 | 5.53x | yes | P/E 48.4x (blended: static sector reference 22x + trailing (TTM) 246x), scenarios: 38.7x / 48.4x / 58.1x (bear / base = reference held flat / bull), EV/EBITDA 35.2x |
| Simple DDM | Growth | — | — | no | — |
| Two-Stage DDM | Growth | — | — | no | — |
| Simple Excess Return | Asset | $15.97 | 22.74x | yes | BV/sh $8.25, ROE (TTM) 17.9%, ke 9.3% (excluded from median) |
| Two-Stage Excess Return | Asset | $21.94 | 16.55x | yes | 5yr excess ROE then converge to ke=9.3% |
| Discounted Future Market Cap | Growth | $96.25 | 3.77x | yes | Rev $1.0B, growth 30% (input: historical growth; tapered), Terminal P/S: 9.6x / 12.0x / 14.4x (bear / base = today's held flat / bull, cap 12x) |
| Peter Lynch Fair Value | Relative | $17.76 | 20.44x | yes | EPS $1.48, growth 2% (input: historical EPS growth), PEG=122.89 (Overvalued) (excluded from median) |
| Margin Trajectory | Growth | — | — | no | — |
| Earnings Power Value | Earnings | $1.78 | 203.99x | yes | Normalized EBIT (3y avg op income, one-time charges added back) $0.03B × (1−21%) / WACC 9.2% → EPV (no growth) (excluded from median) |
| Residual Income | Asset | $21.83 | 16.63x | yes | BV $8.25 + 5yr PV of (ROE (TTM) 17.9% − Kₑ 9.3%) × BV; BV grows 8.8%/yr |
| Graham Number | Asset | $16.57 | 21.91x | yes | √(22.5 × EPS $1.48 × BVPS $8.25) — Graham's conservative floor (excluded from median) |
| EV/EBITDA Relative | Relative | $20.98 | 17.31x | yes | EBITDA $0.23B × sector EV/EBITDA 16.0x |
| FCF Yield | Earnings | $20.82 | 17.44x | yes | FCF $342.8M / Kₑ 9.3% — zero-growth perpetuity |
| SBC-Adj FCF Yield | Earnings | $10.89 | 33.34x | yes | SBC-adj FCF $0.18B (FCF $0.34B − SBC $0.17B) capitalized at Kₑ (excluded from median) |
| Ben Graham Formula | Earnings | $47.75 | 7.60x | yes | EPS $1.48 × (8.5 + 2×15.0%) × (4.4 / 5.3%) |
| ROIC-Justified P/B | Asset | $3.05 | 119.05x | yes | BV $8.25 × (ROIC 3.4% / WACC 9.2%) (excluded from median) |
| P/Sales Sector | Relative | $27.64 | 13.14x | yes | Revenue $1.00B × sector P/S 5.0x |
| PEG Fair Value | Relative | $55.50 | 6.54x | yes | EPS $1.48 × (PEG 1.5 × growth 25.0% (input: historical EPS growth)) → PE 37.5x |
| Earnings Yield | Earnings | $16.00 | 22.69x | yes | EPS $1.48 / required return 9.3% (Rf 4.3% + ERP 5.0%) (excluded from median) |
| Funds From Operations Multiple | Relative | — | — | no | — |
| Clinical Phase NPV | Growth | — | — | no | — |
| Merton | Asset | — | — | no | — |
| V5 Mechanical | — | — | — | no | — |
Solvency
| Field | Value |
|---|---|
| Net cash | $1.2b |
| Net debt / NOPAT (after-tax) | -8.91x (net cash) |
| Net debt / operating income (pre-tax) | -7.04x (net cash) |
| Share count CAGR (dilution) | 19.0% |
| Burning cash | no |
Interest expense is not separately reported in the latest filings, so interest coverage cannot be computed.
Bullet Takeaways
First-quarter 2026 revenue reached $308.4 million, up 93 percent year over year and 14 percent sequentially, on a GAAP gross margin of 76.3 percent, as PCIe Gen 6 and AI fabric products ramped.
The valuation is at the most demanding end of the scale. At about 79 times sales, no standard valuation family reaches the price; the blended methods land near $44 against a $417.77 quote, so the stock is priced beyond what any conventional frame supports.
The company holds roughly $1.18 billion of cash and no debt, and reinvests heavily in a widening product line, the Scorpio fabric switches, set to become its largest product family by year-end. The cash and the roadmap are the bull case; the price is the risk.
Bull Case
The capital-allocation picture is what gives the growth story room to run. Astera Labs holds roughly $1.18 billion in cash and investments with no debt, and rather than return it, the company is plowing it into research and a widening product portfolio. That is the right choice for a company at this stage: it is building connectivity silicon, retimers, PCIe fabric, and switching, that sits in the data path of AI servers, and the way to win there is to keep extending the product line ahead of customer needs. The filing frames the strategy as solving "the data, network, and memory bottlenecks, scalability, and other unique infrastructure requirements of our hyperscaler and system OEM customers," built on "trusted relationships with the lea"ding accounts (FY2025 10-K, accession 0001736297-26-000010). The cash funds that roadmap without dilution from debt.
The reinvestment is converting into a broadening franchise, not a single product. The first quarter of 2026 delivered revenue of $308.4 million, up 93 percent year over year and 14 percent sequentially, at a GAAP gross margin of 76.3 percent and operating margin of 20.1 percent, an unusually profitable profile for a company growing this fast. PCIe Gen 6 already contributes more than a third of revenue, and the newer Scorpio fabric switches, the X-Series 320-lane AI fabric and the expanding P-Series, are ramping toward becoming the largest product line by year-end. A company that can move from one successful product into a second and third, each tied to the same hyperscale customers, is building the kind of multi-product platform that justifies heavy reinvestment.
The demand backdrop is the strongest in technology right now. Astera sells into AI data-center build-outs, where connectivity and fabric bandwidth are genuine bottlenecks, and guidance for the second quarter of $355 to $365 million in revenue with non-GAAP earnings per share of $0.68 to $0.70 implies the ramp continues. The company focuses its efforts on "hyperscalers, leading AI accelerator vendors, and system OEMs" (same filing), exactly the accounts spending the most on AI infrastructure. With a fortress balance sheet, a 76 percent gross margin, and a product roadmap aligned to the largest spending wave in the industry, the business has the financial flexibility to keep investing through the cycle.
Bear Case
The moat is narrower than the valuation assumes, and connectivity silicon is exactly the layer that gets eroded. Astera's products solve real bottlenecks today, but the company competes against far larger semiconductor firms with deeper resources, and its own filing warns that the markets "have been evolving rapidly" so that "some of our competitors may be better situated to meet changing customer needs and secure design wins," and that "increasing competition" may negatively affect results (FY2025 10-K, accession 0001736297-26-000010). The same hyperscalers that are Astera's customers also design their own silicon and back open standards like UALink that are meant to commoditize the fabric layer. A specialized connectivity vendor sitting between giant chip suppliers and giant cloud buyers is structurally squeezable, and a moat built on being first to a standard erodes when the standard matures.
The customer base concentrates that risk. Astera focuses on hyperscalers and leading AI accelerator vendors, and the filing notes that "the universe of availa"ble customers is small (same filing), so a handful of accounts drive the revenue. The design-win model is also fragile: qualification "does not assure any sales," and even after a product is qualified and sold, the relationship can shift (same filing). Losing a socket on the next-generation platform of one large customer, or having that customer move volume in-house, would remove a large slice of revenue at once.
The price assumes none of this happens for a very long time. At about 79 times sales, no valuation family reaches the price; it is rich on assets, earnings power, peers, and even forward growth, with the blended methods near $44 against a $417.77 (June 27, 2026) quote. The inversion treats the price as a bound rather than a solved point, embedding an eventual operating margin above 30 percent and revenue growth beyond 25 percent per year sustained far longer than almost any company achieves. Only about a third of comparable fast-growers held their pace even five years. The heavy stock-based compensation that funds the talent also dilutes holders, with the share count rising at a double-digit rate. A single-layer chip company, dependent on a few customers, facing standards-driven commoditization, priced beyond every standard frame, has an extraordinary amount that must go right and very little room for anything to go wrong.
Valuation
Trailing operating profit sits below the steady-state level the price assumes, so the price is read against sales, and the read is at the most demanding end of the scale. At about 79 times revenue, no valuation family reaches the price: it is rich on assets, earnings power, peers, and even forward growth. The blended central value across the applicable methods sits near $44 against the $417.77 price, a gap of nearly ten to one, which is why the priced-in assumption is labeled extreme.
Inverting the price gives a bound, not a solved point. It implies the business eventually earns an operating margin above 30 percent and sustains revenue growth beyond 25 percent per year for a span so long, on the order of decades, that it is not resolvable as an ordinary revenue bet. Historically only about a third of comparable fast-growers sustained their pace even five years, so the implied durability is far outside the base rate. The company's fundamentals are genuinely strong: a 76 percent gross margin, 93 percent year-over-year revenue growth, roughly $1.18 billion of net cash, and a broadening product line. But the valuation is not pricing the strong fundamentals; it is pricing a near-perfect, multi-decade continuation of them, against competition from much larger chip companies and against standards designed to commoditize the connectivity layer. The investment case is therefore almost entirely about whether Astera can defend and extend its position long enough to grow into a price that no conventional method can justify today. The upside requires the AI connectivity wave to keep building and Astera to keep winning the sockets; the downside is that any slowing of growth, margin, or design-win momentum collapses the gap toward the static methods, which see a fraction of the current price.
Catalysts
The Scorpio fabric ramp is the central catalyst. The Scorpio X-Series 320-lane AI fabric switch and the expanding P-Series are ramping, and management expects Scorpio to become the largest product line by year-end, surpassing the P-Series in revenue. The pace of that ramp, and whether Scorpio scales as guided, is the key signal that Astera is broadening from one product into a platform. PCIe Gen 6 already contributes more than a third of revenue.
The near-term proof point is execution against guidance. Second-quarter 2026 guidance of $355 to $365 million in revenue with non-GAAP earnings per share of $0.68 to $0.70 implies continued strong growth, and the second-half production ramps are where execution risk concentrates. Watch revenue, gross margin, and any change to the ramp timeline, since a 79-times-sales valuation reacts sharply to any deceleration.
Design wins and standards are the swing factors. The uptake of newer solutions like UALink 2.0-based fabrics across hyperscale AI infrastructure cuts both ways: winning those sockets extends the runway, while open standards maturing could commoditize the fabric layer. New design wins at hyperscalers and accelerator vendors are positive catalysts; any sign of a customer moving volume in-house or to a competitor is the principal downside trigger. Quarterly results remain the main proof point on whether the growth and margin profile is holding.
Peer Cohorts (Per Segment, With Filing Citations)
Astera Labs (consolidated) (reported)
- CRDO (CREDO TECHNOLOGY GROUP HOLDING LTD)
- FY2025 10-K: …and Astera Labs, Inc. (Astera), as well as various cable suppliers. We expect competition will increase as our market grows, connectivity technology advances and existing competitors improve or expand their product offerings. In addition, new companies could enter our market, creating additional competition in the…
- FY2025 10-K: …suite of high-performance connectivity solutions. Our competitors typically compete with us with respect to some, but not all, of our solutions. Our principal competitors with respect to our products include Broadcom Ltd. (Broadcom), Marvell Technology, Inc. (Marvell) and Astera Labs, Inc. (Astera), as well as…
- MXL (MaxLinear, Inc.)
- FY2025 10-K: …in the form of units of products which are included in accrued expenses and other current liabilities in the consolidated balance sheets. Other obligations to customers, which are included in accrued price protection liability in the consolidated balance sheets, consist of estimates of price protection rights offered…
- FY2025 10-K: Consolidated Complaint alleged that the defendants made false and misleading statements and/or omitted material facts that MaxLinear had a duty to disclose, concerning the Company's intention to close the merger with Silicon Motion. On August 28, 2024, the court granted the defendants a motion to dismiss holding that…
- RMBS (RAMBUS INC)
- FY2025 10-K: …financial statements and related disclosures. In July 2025, the FASB issued ASU No. 2025-05, "Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets." This guidance provides public business entities with a practical expedient when estimating expected…
- FY2025 10-K: CONSOLIDATED FINANCIAL STATEMENTS (Continued) The Company's accounts receivable are derived from revenue earned from customers located in the U.S. and internationally. Refer to Note 7, "Segments and Major Customers," for additional information. The Company's unbilled receivables are collected from customers located in…
- MTSI (MACOM Technology Solutions Holdings, Inc.)
- FY2025 10-K: …court rulings. We recognize potential liabilities for anticipated tax audit matters in the United States and other tax jurisdictions based on our estimate of whether, and the extent to which, additional taxes and interest will be due. We record an amount as an estimate of probable additional income tax liability at…
- FY2025 10-K: …(SSPAs), microwave predistortion linearizers and microwave photonics based in Hamilton, New Jersey (the "Linearizer Acquisition"), which was accounted for as a business combination. We acquired Linearizer to further strengthen our component and subsystem design expertise in our target markets. In connection with the…
- SLAB (SILICON LABORATORIES INC.)
- FY2025 10-K: …those annual reporting periods. Entities may apply the guidance using a prospective, retrospective or modified transition approach. Early adoption is permitted as of the beginning of an annual reporting period. The Company is currently evaluating the effect of this new guidance on its consolidated financial…
- FY2025 10-K: …customers, product life cycles and market conditions, as applicable) with the Company's forecast. • We considered, when relevant, the existence of contradictory evidence based on reading of internal financial and operational information used by management and the board of directors, Company press releases, and…
- LSCC (Lattice Semiconductor Corp)
- FY2025 10-K: …widely used in communications and high-speed industrial applications. To enable our customers to get to market faster, we support our FPGAs with IP cores, reference designs, development kits, and design software. We are investing in our design software, such as Lattice Radiant™, to deliver best-in-class tools that…
- FY2025 10-K: …its Chief Executive Officer. As of January 3, 2026, we have determined that the Company operates in a single operating and reportable segment: the core Lattice business, which includes silicon-based and silicon-enabling products, evaluation boards, development hardware, and related intellectual property licensing,…
- SITM (SITIME Corp)
- FY2025 10-K: …in net proceeds to us of $64.3 million, after deducting underwriting discounts and commissions of $1.3 million and offering costs of $0.6 million. The net proceeds from the Sales Agreement were offset by tax withholdings paid on behalf of employees for net share settlement of $54.6 million, payment towards the Aura…
- FY2025 10-K: …ASU No. 2024-03, Disaggregation of Income Statement Expenses (Subtopic 220-40). The ASU requires the disaggregated disclosure of specific expense categories, including purchases of inventory, employee compensation, depreciation, and amortization, within relevant income statement captions. This ASU also requires…
- SIMO (Silicon Motion Technology Corporation)
- (no filing in the citation store)
Methodology Note
- Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
- Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
- Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
- Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.
Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.